4//SEC Filing
Meredith Ian T 4
Accession 0001225208-22-002921
CIK 0000885725other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:45 PM ET
Size
13.3 KB
Accession
0001225208-22-002921
Insider Transaction Report
Form 4
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
- Exercise/Conversion
Common Stock
2022-02-17+1,250→ 32,871 total - Exercise/Conversion
Restricted Stock Units
2022-02-17−1,250→ 3,750 totalExp: 2025-02-17→ Common Stock (1,250 underlying) - Tax Payment
Common Stock
2022-02-17$42.83/sh−367$15,719→ 32,504 total - Exercise/Conversion
Common Stock
2022-02-18+1,037→ 33,541 total - Tax Payment
Common Stock
2022-02-18$42.55/sh−305$12,978→ 33,236 total - Exercise/Conversion
Deferred Stock Units
2022-02-18−1,037→ 2,076 totalExp: 2024-02-18→ Common Stock (1,037 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F2]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- [F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001693920
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:45 PM ET
- Size
- 13.3 KB